GRDN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Guardian Pharmacy Services Inc (GRDN) is not a strong buy for a beginner, long-term investor at this time. While the company has shown revenue growth, the significant drop in net income and EPS, combined with neutral technical indicators and lack of strong trading signals, suggest that waiting for clearer positive trends or catalysts would be prudent.
The MACD is negative and expanding downward (-0.103), indicating bearish momentum. RSI is neutral at 51.492, showing no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the price is below the pivot level (33.283), with support at 32.076 and resistance at 34.49. Overall, the technical indicators are mixed and do not suggest a strong buy signal.
Revenue increased by 20.05% YoY in Q3 2025, and gross margin improved by 2.27% YoY to 19.8%.
No recent news, no significant hedge fund or insider trading activity, and no recent congress trading data. Technical indicators are neutral to slightly bearish, and no strong trading signals are present.
In Q3 2025, revenue grew by 20.05% YoY to $377.43M, but net income dropped significantly by -108.05% YoY to $9.82M. EPS also fell by -108.00% YoY to $0.16. Gross margin improved slightly to 19.8%, up 2.27% YoY.
No data available for analyst ratings or price target changes.
